요오드화 조영제 부작용: 성분별 발생 빈도 비교
Incidence of adverse drug reaction among 6 iodinated contrast media
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: Contrast media is one of the most common cause of adverse drug reaction (ADR) in adult. However, there was little data reported about differences in ADR ratio and severity among iodinated contrast media (ICM). Methods: Medical records of 627,049 patients who performed computed tomography scan using low-osmolar nonionic iodinated contrast media from January 2015 to December 2018 were retrospectively reviewed. A total of 6 ICMs including iomeprol, iohexol, iopromide, iobitridol, ioversol, and iopamidol were used in this period. The incidence of ADR was compared to their total usage and dosage between each contrast media. Results: The incidence of ADR of iopromide (1.36%) and iomeprol (1.27%) was the highest when compared with the average incidence of 1% of 6 ICMs. Ioversol (0.67%), iohexol, and iobitridol (0.74%) had the lower incidence of ADR. The order of results adjusted by actual administered dosage, the use of premedication, and the prior exposure history of ICMs was similar. The fraction of moderate and severe ADR in overall ADR was slightly different, but not proportional to the incidence of ADR. Conclusion: The incidence of ADR among 6 low-osmolar nonionic ICMs was significantly different when compared by the total number of usage and the total volume of dose. The incidence of ADR varied by nearly 2-fold depending on ICMs. Further study might need to explore the reason for the difference of incidence.
Abstract
Purpose: Contrast media is one of the most common cause of adverse drug reaction (ADR) in adult. However, there was little data reported about differences in ADR ratio and severity among iodinated contrast media (ICM). Methods: Medical records of 627,049 patients who performed computed tomography scan using low-osmolar nonionic iodinated contrast media from January 2015 to December 2018 were retrospectively reviewed. A total of 6 ICMs including iomeprol, iohexol, iopromide, iobitridol, ioversol, and iopamidol were used in this period. The incidence of ADR was compared to their total usage and dosage between each contrast media. Results: The incidence of ADR of iopromide (1.36%) and iomeprol (1.27%) was the highest when compared with the average incidence of 1% of 6 ICMs. Ioversol (0.67%), iohexol, and iobitridol (0.74%) had the lower incidence of ADR. The order of results adjusted by actual administered dosage, the use of premedication, and the prior exposure history of ICMs was similar. The fraction of moderate and severe ADR in overall ADR was slightly different, but not proportional to the incidence of ADR. Conclusion: The incidence of ADR among 6 low-osmolar nonionic ICMs was significantly different when compared by the total number of usage and the total volume of dose. The incidence of ADR varied by nearly 2-fold depending on ICMs. Further study might need to explore the reason for the difference of incidence.
참고문헌 (33)
- 성종미, "Comparison of the Safety of Seven Iodinated Contrast Media", Journal of Korean Medical Science, 28(12), pp.1703~1710 (2013), 대한의학회
- Kim MH, "Surveillance of contrast-media-induced hypersensitivity reactions using signals from an electronic medical recording system", Ann Allergy Asthma Immunol, 108, pp.167~171 (2012)
- Lee SY, "Radiocontrast media hypersensitivity in the Asia Pacific region", Asia Pac Allergy, 4, pp.119~125 (2014)
- 조민경, "요오드화 조영제 과민반응에 대한 임상 대처 최신 지견", Allergy Asthma & Respiratory Disease, 8(3), pp.107~113 (2020), 대한 소아알레르기 호흡기학회[DOI]
- An J, "Differences in adverse reactions among iodinated contrast media : analysis of the KAERS database", J Allergy Clin Immunol Pract, 7, pp.2205~2211 (2019)
- Korean Society of Radiology, "Korean clinical practice guideline on adverse reactions of injectable iodinated contrast agent and gadolinium contrast agent for MRI", Korean Society of Radiology, ~ (2016)
- 신명진, "요오드화 조영제 유해반응의 예방과 치료", 대한의사협회지, 55(8), pp.779~790 (2012), 대한의사협회[DOI]
- Katayama H, "Adverse reactions to ionic and nonionic contrast media. a report from the Japanese Committee on the Safety of Contrast Media", Radiology, 175, pp.621~628 (1990)
- 김선신, "일반인에서 컴퓨터 단층촬영에 사용되는 조영제 과민반응의 발생빈도와 임상양상", 천식 및 알레르기, 27(3), pp.157~161 (2007), 대한천식알레르기학회
- Meth MJ, "Current understanding of contrast media reactions and implications for clinical management", Drug Saf, 29, pp.133~141 (2006)
- Idee JM, "Allergy-like reactions to iodinated contrast agents. A critical analysis", Fundam Clin Pharmacol, 19, pp.263~281 (2005)
- 장광천, "한국 아나필락시스의 진료", Allergy Asthma & Respiratory Disease, 1(3), pp.181~196 (2013), 대한 소아알레르기 호흡기학회
- Korean Society of Radiology, "CT examination and repeat CT examination guidelines", Health Insurance Review & Assessment Service, ~ (2013)
- 김영진, "대한심장혈관영상의학회 심장 CT 권고안", 대한영상의학회지, 65(3), pp.303~315 (2011), 대한영상의학회
- Kim EY, "Image quality and attenuation values of multidetector CT coronary angiography using high iodine-concentration contrast material: a comparison of the use of iopromide 370 and iomeprol 400", Acta Radiol, 51, pp.982~989 (2010)
- "ACR manual on contrast media. Version 10.3" (2017)[URL]
- "The WHO adverse reaction terminology (WHO-ART): terminology for coding clinical information in relation to drug therapy"[URL]
- Brockow K, "Management of hypersensitivity reactions to iodinated contrast media", Allergy, 60, pp.150~158 (2005)
- Lee SY, "Incidence and risk factors of immediate hypersensitivity reactions associated with low-osmolar iodinated contrast media : a longitudinal study based on a real-time monitoring system", J Investig Allergol Clin Immunol, 29, pp.444~450 (2019)
- Yang MS, "Epidemiologic and clinical features of anaphylaxis in Korea", Ann Allergy Asthma Immunol, 100, pp.31~36 (2008)
- Gomi T, "Are there any differences in acute adverse reactions among five low-osmolar non-ionic iodinated contrast media", Eur Radiol, 20, pp.1631~1635 (2010)
- Wang CL, "Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions", AJR Am J Roentgenol, 191, pp.409~415 (2008)
- Vogl TJ, "Safety of iobitridol in the general population and at-risk patients", Eur Radiol, 16, pp.1288~1297 (2006)
- Cochran ST, "Trends in adverse events after IV administration of contrast media", AJR Am J Roentgenol, 176, pp.1385~1388 (2001)
- Bae YJ, "The effectiveness of automatic recommending system for premedication in reducing recurrent radiocontrast media hypersensitivity reactions", PLoS One, 8, pp.e66014~ (2013)
- Cha MJ, "Hypersensitivity reactions to iodinated contrast media : a multicenter study of 196 081 patients", Radiology, 293, pp.117~124 (2019)
- Wolf GL, "A prospective trial of ionic vs nonionic contrast agents in routine clinical practice : comparison of adverse effects", AJR Am J Roentgenol, 152, pp.939~944 (1989)
- Lasser EC, "Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media", AJR Am J Roentgenol, 162, pp.523~526 (1994)
- Jost G, "The impact of the viscosity and osmolality of iodine contrast agents on renal elimination", Invest Radiol, 45, pp.255~261 (2010)
- Lenhard DC, "The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety", Invest Radiol, 47, pp.503~510 (2012)
- Vahldiek JL, "Effect of different iodine concentrations on patient-reported discomfort in contrast-enhanced computed tomography : a prospective comparative trial", Rofo, 192, pp.945~951 (2020)
- Lerondeau B, "Analysis of cross-reactivity among radiocontrast media in 97 hypersensitivity reactions", J Allergy Clin Immunol, 137, pp.633~635 (2016)
- Clement O, "Immediate hypersensitivity to contrast agents : the french 5-year CIRTACI study", EClinicalMedicine, 1, pp.51~61 (2018)